Edgewise Therapeutics Inc...

NASDAQ: EWTX · Real-Time Price · USD
14.04
0.11 (0.79%)
At close: Aug 15, 2025, 3:05 PM

Edgewise Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
2.29M 1.73M 538K 272K
Gross Profit
-2.29M -1.73M -538K -272K
Operating Income
-158.83M -114.36M -22.08M -43.22M
Interest Income
25.02M 14.19M 2.66M 402K
Pretax Income
-133.81M -100.16M -67.64M -42.81M
Net Income
-133.81M -100.16M -67.64M -42.81M
Selling & General & Admin
31.87M 23.45M 5.47M 11.03M
Research & Development
126.97M 89.35M 16.61M 32.19M
Other Expenses
-2.29M -181K 49.58M n/a
Operating Expenses
156.54M 112.63M 71.66M 43.22M
Interest Expense
n/a n/a 4.02M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
158.83M 114.36M 71.66M 43.22M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
92.41M 63.72M 53.59M 49.5M
Shares Outstanding (Diluted)
92.41M 63.72M 53.59M 49.5M
EPS (Basic)
-1.45 -1.57 -1.26 -0.86
EPS (Diluted)
-1.45 -1.57 -1.26 -0.86
EBITDA
-131.52M -112.81M -67.1M -42.94M
EBIT
-133.81M -114.36M -67.64M -43.22M
Depreciation & Amortization
2.29M 1.73M 538K 272K